Clinical Trial Update: Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating BCMA/CD70 CAR-T therapy for refractory childhood-onset systemic lupus erythematosus (cSLE) is currently recruiting. Sponsored …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• BCMA/CD70 CAR-T therapy

Snippet

Sponsor: The Children's Hospital of Zhejiang University School of Medicine | Conditions: CAR T Cell Therapy, Systemic Lupus Erythematosus | Phase 1 | Status: RECRUITING